This provider of outpatient diagnostic imaging services has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
RadNet currently holds a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.
Investors interested in the broader healthcare sector may also consider stocks like Natus Medical Inc. (BABY), Allergan Inc. (AGN) and Affymetrix Inc. (AFFX). All three stocks bear the same Zacks Rank as RadNet.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment